U.S. Paper and Forestry Products Stock News

Liquidity Services entered this earnings release with a quietly strong run, with the stock up around 16% over the past three months, and the market barely flinched today with a 0.1% move. That calm surface hides a punchy quarter. The company posted Q3 revenue of US$129.6m and basic earnings per share of US$0.33, while gross merchandise volume reached US$453m. Management also highlighted its 10th straight quarter of year over year adjusted EBITDA growth, which puts execution, not hype, at the...

Tariffs on imported polysilicon and new minimum prices on some solar imports have suddenly put a spotlight on U.S. solar energy stocks. With First Solar and Solaredge Technologies reacting quickly in premarket trading, investors are watching for potential winners from reduced Chinese competition and a possible lift to domestic manufacturing. This article walks through three U.S. solar related stocks exposed to this news and explains why their stories matter now. The stocks covered below are...

Xeris Biopharma walked into this earnings print with a stock that had slipped over the past month and week, yet the market snapped back fast. The share price jumped 7.6% today to US$7.92. That reaction is all about one thing. Investors saw a high growth specialty pharma story deliver record Q2 revenue of US$92.1m while absorbing a sizeable one time noncash GAAP hit tied to retiring its 2028 convertible notes. The headline is simple. Strong top line momentum collided with a cleaner capital...

Republic Services walked into this earnings day with a reputation as a steady compounder and a stock that had cooled slightly over the past month. The market did not wait for the clean up. Shares jumped about 2.4% to around US$214.51 as investors digested a quarter built on firm pricing power and a raised full year outlook. For a waste and environmental services stock, the headline is simple. Revenue of US$4.43b and adjusted earnings per share of about US$1.85 reinforced the story that...

BioMarin Pharmaceutical stock closed up 3.7% at US$63.75, which indicates the market responded positively to the news. The question is whether that move really reflects what just happened in the quarter. Revenue was approximately US$989.7m in Q2 while basic earnings per share came in at US$0.23, and management raised full year guidance for both sales and non generally accepted accounting principles earnings per share. In short, traders were willing to pay more for BioMarin Pharmaceutical...

Summit Hotel Properties came into this print looking like a recovery value story, with the stock up over the past three months but slipping 2.8% today to US$6.49 as investors digested the latest numbers. The headline is simple. Q2 flipped back into the black on a basic earnings per share basis and management backed that up with a higher full year outlook for adjusted funds from operations and revenue per available room. For a hotel real estate investment trust, that shift in profitability and...

Establishment Labs Holdings slipped 2.2% to US$77.33 after its Q2 report, a muted move for a stock that has already been soft over the past month. The headline is simple: revenue reached US$67.5m and the company turned adjusted EBITDA positive at US$3.7m while pushing gross margin to 70.6%. The near term story is still about losses and a premium valuation, with the stock trading on a trailing P/S of 9.3x versus much lower industry averages. The longer term question is whether the minimally...

Millicom International Cellular stock took a sharp hit, dropping about 7% today, even as the quarter delivered headline numbers many telecom investors usually want to see. Service revenue reached about US$2.0b and adjusted earnings before interest, tax, depreciation and amortisation climbed to a record US$1.0b, with a strong equity free cash flow print of US$327m. For a company often framed as a balance between growth and balance sheet risk, that selloff sets up a clear tension. The market...

The market just swung hard in Twilio’s favor, with the stock jumping almost 25% in a single session, and the core reason sits squarely in profitability. Q2 basic earnings per share moved to about US$7 on roughly US$1.5b of revenue, turning a company long treated as a growth story into a clear profit story. That kind of earnings power in a communications software stock can quickly reset investor expectations. Today’s surge looks like a sentiment reset driven less by hype and more by a sharp...

White Mountains Insurance Group stock barely flinched after earnings, ticking up about 0.5% to around US$2,152. For a company with a US$80.58 quarterly earnings per share print and an 83.9% combined ratio in its core insurance operations, that is a muted response. The focus for you is not today’s move; it is that these results land on top of a trailing 12 month earnings profile shaped by a very large one off gain and a P/E of 4.6x that keeps the long term valuation debate wide open. Is White...

DNOW stock jumped 7.3% today, yet the headline story is not a sudden growth re-rating. It is that a chronic loss maker just printed another loss, only smaller. Revenue for the quarter came in at US$1.31b while DNOW reported a net loss of US$21m. That is a clear improvement on the US$44m loss in the prior quarter. For a stock that screens as cheap on simple sales multiples and discounted cash flow math, this quarter is about one thing: the profit squeeze is easing, but the turnaround is still...

FIGS jumped 27% today, with the stock closing near US$14 after a strong earnings jolt that caught short term traders off guard. The scrubwear specialist did not just post another solid quarter. It put profit margins at the center of the story. Net revenue reached US$196.6m for the quarter while net income was US$28.4m, and management lifted full year guidance for both revenue growth and adjusted EBITDA margin. The market reacted to the headline surprise. Long term holders will focus on...

Prestige Consumer Healthcare stock barely flinched after earnings, up less than 1% to about $54.90, which suggests investors saw nothing to disrupt the long term thesis on this consumer health compounder. The headline is quieter than the quarter. Revenue came in at about $265.7m and adjusted earnings per share ticked higher to $0.98, while free cash flow hit a record $83.7m. The real story for you is not a big beat or miss. It is how Prestige Consumer Healthcare is using that cash firepower...

Warner Bros. Discovery stock barely flinched after earnings, inching up about 1% to sit slightly above where it traded over the past month. For a media stock with headline losses and an ongoing turnaround story, that is a surprisingly calm verdict. The market appears to be keying off the streaming story, where Q2 revenue moved past US$3.0b and adjusted EBITDA hit US$512m, rather than fixating on past net losses. In other words, today’s move looks less like euphoria or panic and more like...

RLJ Lodging Trust just reminded investors that hotel stocks can surprise in both directions. The share price dropped 6.6% to about US$11.14 on the first trading day after earnings, even though the quarter showed solid execution in the areas that matter most for a real estate investment trust in hotels. Adjusted funds from operations per share landed at US$0.52, and comparable revenue per available room rose enough for management to lift full year guidance. Coming into this earnings report,...

First Advantage walked into this earnings print with the stock sitting near US$24 and a strong three month run behind it, yet the immediate reaction was a mild 0.5% slip. For a company often framed as a premium priced background screening platform with plenty of future promises baked in, the headline this quarter is simpler. Profit is now showing up in the numbers. The market marked the stock down on the day while First Advantage posted Q2 revenue of US$448.8m and basic earnings per share of...

Aclaris Therapeutics stock slipped about 3% today, which looks mild compared with the strain running through its income statement. The headline from this quarter is the earnings drag, not the revenue line. Aclaris booked Q2 revenue of US$1.6 million yet reported a net loss of US$21.5 million, keeping earnings per share in loss territory at roughly US$0.15 per share. For a clinical stage biotech, that scale of loss against such a small revenue base is what is driving sentiment now. The market...

ICF International stock climbed 11.4% to about US$95 today, as investors moved to reprice what appeared to be a routine consulting quarter into something more notable. The main focus is earnings power. Q2 non GAAP earnings per share came in at US$1.86, while adjusted EBITDA margin was 11.2%, and the stock still trades on a P/E that is below both industry and peer averages. Short term traders experienced a price jump. Long term holders are weighing a multi year earnings growth forecast that...

Axcelis Technologies stock was already under pressure over the last three months, then jumped about 2.5% to roughly US$140 once investors saw the second quarter report. The move looks modest next to the recent 13.9% three month decline, yet the headline numbers point straight at profitability stress. Trailing net profit margin now sits at 10.7% compared with 17.7% a year earlier, while the valuation still implies a rich future with a P/E around 46.7x. The real question for you is whether this...

Monster Beverage just took a 4% hit in a single session, yet the earnings story behind that move looks far calmer than the price chart. The stock came into today already soft over the past month, and the latest quarter delivered record net sales of about US$2.54b with basic earnings per share near US$0.60. The market is reacting as if this is a crack in the growth story. The core numbers suggest the real debate is not about whether Monster is making money, but whether investors still want to...

Playtika Holding entered this quarter with a reputation as a low-priced mobile gaming stock with heavy baggage. The stock had already slipped over the past month and then dropped another 10.9% to US$2.93 after the Q2 release. The headline is not revenue; the real story is margin repair. Adjusted EBITDA rose to US$206.1m with a 28.2% margin as Playtika aggressively cut user acquisition spend and focused on its direct to consumer channels. Is Playtika Holding a genuine bargain at a low P/S of...

Amplitude stock closed up 4.6% at about US$11.26, which suggests traders liked what they saw. The real story is not just the beat and raise chatter. It is that a still unprofitable software company reported US$100.9m in quarterly revenue and a record US$23.7m in free cash flow in the same period. For a product analytics and experimentation platform that has operated with losses, that free cash flow figure is the sentiment swing factor. The stock had already climbed strongly over the past...

Lionsgate Studios stock barely budged after earnings, up about 0.3% and still lower over the past month. This suggests investors are unsure how to price what just happened. On the surface, the company reported another quarterly loss, with basic earnings per share in the red and net income still negative. Yet the headline story is different. Revenue in Q1 Fiscal 2027 reached about US$776.6m and free cash flow hit US$129m, while net debt moved lower. The market reaction looks muted compared...

International Bancshares stock slipped about 2.1% to around US$73.54 after its latest earnings, even though the core profit engine still looks solid. The headline this quarter is margins. Net income excluding extra items came in at US$95.81 million on US$203.72 million of revenue, which keeps profitability high but just a touch softer than recent quarters. For short term traders, that slight margin squeeze adds pressure to a stock that has edged down over the past week and month. Long term...